Lexicon Pharmaceuticals
LXRX
#6677
Rank
NZ$1.21 B
Marketcap
NZ$2.86
Share price
0.00%
Change (1 day)
142.81%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.32. In 2024 the company made an earnings per share (EPS) of NZ-$1.09 an increase over its 2023 EPS that were of NZ-$1.36.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-69.16%
2024NZ-$1.09-20%
2023NZ-$1.3631.15%
2022NZ-$1.04-0%
2021NZ-$1.0410.91%
2020NZ-$0.94-145.08%
2019NZ$2.07-206.09%
2018NZ-$1.96-5.74%
2017NZ-$2.07-10.95%
2016NZ-$2.332640%
2015NZ-$0.08503-96.34%
2014NZ-$2.32-2.53%
2013NZ-$2.38-9.09%
2012NZ-$2.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$30.22-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.32-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$73.33-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$9.93 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$10.71-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.85 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.28 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$3.09-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$130.45 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA